Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario La Fe (48)

2024

  1. AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action

    Science advances, Vol. 10, Núm. 41, pp. eadn6525

  2. Deletion of exons 45 to 55 in the DMD gene: from the therapeutic perspective to the in vitro model

    Skeletal muscle, Vol. 14, Núm. 1, pp. 21

2023

  1. Quantitative magnetic resonance imaging assessment of muscle composition in myotonic dystrophy mice

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Dystrophinopathy Phenotypes and Modifying Factors in DMD Exon 45–55 Deletion

    Annals of Neurology, Vol. 92, Núm. 5, pp. 793-806

  2. Phenotype and Distribution of Immature Neurons in the Human Cerebral Cortex Layer II

    Frontiers in Neuroanatomy, Vol. 16

2021

  1. A study of the phenotypic variability and disease progression in Laing myopathy through the evaluation of muscle imaging

    European Journal of Neurology, Vol. 28, Núm. 4, pp. 1356-1365

  2. Duchenne muscular dystrophy cell culture models created by CRISPR/Cas9 gene editing and their application in drug screening

    Scientific Reports, Vol. 11, Núm. 1

  3. Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy

    Molecular Therapy - Nucleic Acids, Vol. 26, pp. 174-191

2019

  1. Changes in Adrenoceptor and GRK Expression in Patients With Chronic Pulmonary Regurgitation

    Revista Espanola de Cardiologia, Vol. 72, Núm. 7, pp. 569-576

  2. In vitro study of antimicrobial activity on Klebsiella Pneumoniae biofilms in endotracheal tubes

    Journal of Chemotherapy, Vol. 31, Núm. 4, pp. 202-208

  3. Β2-adrenoceptors and GRK2 as potential biomarkers in patients with chronic pulmonary regurgitation

    Frontiers in Pharmacology, Vol. 10, Núm. FEB

2018

  1. Imiquimod inhibits growth and induces differentiation of myeloid leukemia cell lines

    Cancer Cell International, Vol. 18, Núm. 1

2017

  1. Activation of α1A-adrenoceptors desensitizes the rat aorta response to phenylephrine through a neuronal NOS pathway, a mechanism lost with ageing

    British Journal of Pharmacology, Vol. 174, Núm. 13, pp. 2015-2030

  2. RyR2R420Q catecholaminergic polymorphic ventricular tachycardia mutation induces bradycardia by disturbing the coupled clock pacemaker mechanism

    JCI insight, Vol. 2, Núm. 8

  3. Untargeted metabolomics of fresh and heat treatment Tiger nut (Cyperus esculentus L.) milks reveals further insight into food quality and nutrition

    Journal of Chromatography A, Vol. 1514, pp. 80-87

2016

  1. Immunoproteomic studies on paediatric opsoclonus-myoclonus associated with neuroblastoma

    Journal of Neuroimmunology, Vol. 297, pp. 98-102

  2. Modulation of copper deficiency responses by diurnal and circadian rhythms in Arabidopsis thaliana

    Journal of Experimental Botany, Vol. 67, Núm. 1, pp. 391-403

2015

  1. Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 Drosophila model

    DMM Disease Models and Mechanisms, Vol. 8, Núm. 7, pp. 679-690

  2. β2-and β1-adrenoceptor expression exhibits a common regulatory pattern with GRK2 and GRK5 in human and animal models of cardiovascular diseases

    Journal of Cardiovascular Pharmacology, Vol. 66, Núm. 5, pp. 478-486

2014

  1. Antihypertensive mechanism of lactoferrin-derived peptides: Angiotensin receptor blocking effect

    Journal of Agricultural and Food Chemistry, Vol. 62, Núm. 1, pp. 173-181